155 related articles for article (PubMed ID: 19662384)
1. Specific effects of escitalopram on neuroendocrine response.
Hawken ER; Owen JA; Hudson RW; Delva NJ
Psychopharmacology (Berl); 2009 Nov; 207(1):27-34. PubMed ID: 19662384
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
Nadeem HS; Attenburrow MJ; Cowen PJ
Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral racemic citalopram on neuroendocrine responses.
Hawken ER; Owen JA; Van Vugt D; Delva NJ
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):694-700. PubMed ID: 16563590
[TBL] [Abstract][Full Text] [Related]
4. L-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.
Lowe SL; Yeo KP; Teng L; Soon DK; Pan A; Wise SD; Peck RW
Psychoneuroendocrinology; 2006 May; 31(4):473-84. PubMed ID: 16378695
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.
Lotrich FE; Bies R; Muldoon MF; Manuck SB; Smith GS; Pollock BG
Psychopharmacology (Berl); 2005 Mar; 178(2-3):268-75. PubMed ID: 15365685
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation.
Garcia-Leal C; Del-Ben CM; Leal FM; Graeff FG; Guimarães FS
J Psychopharmacol; 2010 May; 24(5):683-94. PubMed ID: 19251828
[TBL] [Abstract][Full Text] [Related]
7. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
Jacquot C; David DJ; Gardier AM; Sánchez C
Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men.
Jezová D; Duncko R
J Psychopharmacol; 2002 Sep; 16(3):235-40. PubMed ID: 12236631
[TBL] [Abstract][Full Text] [Related]
9. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects.
Seifritz E; Müller MJ; Annen O; Nil R; Hatzinger M; Hemmeter U; Moore P; Holsboer-Trachsler E
J Psychiatr Res; 1997; 31(5):543-54. PubMed ID: 9368196
[TBL] [Abstract][Full Text] [Related]
10. State and trait abnormalities in serotonin function in major depression.
Bhagwagar Z; Whale R; Cowen PJ
Br J Psychiatry; 2002 Jan; 180():24-8. PubMed ID: 11772847
[TBL] [Abstract][Full Text] [Related]
11. Improved potency of escitalopram on the human serotonin transporter: demonstration of an ex vivo assay technique.
Rausch JL; Corley KM; Hobby HM
J Clin Psychopharmacol; 2004 Apr; 24(2):209-13. PubMed ID: 15206668
[TBL] [Abstract][Full Text] [Related]
12. Low-dose citalopram as a 5-HT neuroendocrine probe.
Attenburrow MJ; Mitter PR; Whale R; Terao T; Cowen PJ
Psychopharmacology (Berl); 2001 May; 155(3):323-6. PubMed ID: 11432696
[TBL] [Abstract][Full Text] [Related]
13. The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats.
Mørk A; Kreilgaard M; Sánchez C
Neuropharmacology; 2003 Aug; 45(2):167-73. PubMed ID: 12842122
[TBL] [Abstract][Full Text] [Related]
14. The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression-A randomised trial.
Knorr U; Vinberg M; Gether U; Winkel P; Gluud C; Wetterslev J; Kessing LV
Psychiatry Res; 2012 Dec; 200(2-3):354-60. PubMed ID: 22703642
[TBL] [Abstract][Full Text] [Related]
15. Escitalopram: a review of its use in the management of anxiety disorders.
Dhillon S; Scott LJ; Plosker GL
CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656
[TBL] [Abstract][Full Text] [Related]
16. [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].
Owens JM; Knight DL; Nemeroff CB
Encephale; 2002; 28(4):350-5. PubMed ID: 12232544
[TBL] [Abstract][Full Text] [Related]
17. Acute hormonal changes after IV citalopram and treatment response in OCD.
Corregiari FM; Gattaz WF; Bernik M
Psychopharmacology (Berl); 2007 Sep; 193(4):487-94. PubMed ID: 17492272
[TBL] [Abstract][Full Text] [Related]
18. Acute citalopram administration produces correlated increases in plasma and salivary cortisol.
Bhagwagar Z; Hafizi S; Cowen PJ
Psychopharmacology (Berl); 2002 Aug; 163(1):118-20. PubMed ID: 12185409
[TBL] [Abstract][Full Text] [Related]
19. Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration.
Dong C; Zhang JC; Yao W; Ren Q; Yang C; Ma M; Han M; Saito R; Hashimoto K
Pharmacol Biochem Behav; 2016 May; 144():7-12. PubMed ID: 26892759
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram: a unique mechanism of action.
Bræstrup C; Sanchez C
Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():11-3. PubMed ID: 24930683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
